| 
							
      					 | 
  					 
  					
    					 | 
   					 
   										
    					| Analysis of Curative Effect and Curative Effect Predictors of First-line Use of Sintilimab Combined with SOX Regimen in Patients with Advanced Gastric Cancer | 
  					 
  					  										
						| YIN Mingmei, FENG Jiangshan, ZHAO Zheng, ZHAO Weifeng, WANG Chaojie | 
					 
															
						| First-author's address: People's Hospital of Henan University, Zhengzhou 450003, China | 
					 
										
						 | 
					 
				 
				
				
			
		 |